US2005186283A1PendingUtilityA1
Collagen carrier of therapeutic genetic material, and method
Est. expiryOct 10, 2017(expired)· nominal 20-yr term from priority
A61P 43/00A61L 27/36A61F 2210/0004A61K 48/0075A61F 2310/00365A61L 31/14A61F 2002/30761A61L 2300/414A61F 2002/30677A61F 2310/00982A61F 2002/0086A61L 31/044A61F 2002/4635A61K 9/0024A61L 27/20A61F 2002/3093A61L 15/325A61L 15/40A61L 27/54A61L 27/24A61F 2002/30062A61K 9/7023A61F 2/28A61L 27/3847A61L 31/16A61B 17/00491A61B 17/00234A61F 2/0077A61L 2300/258A61F 2002/30932A61F 2002/009A61F 2002/2817A61B 17/06166A61L 27/3852A61F 2/30767A61L 2430/06A61L 31/005A61F 2240/001A61K 38/1875A61F 2002/30971A61F 2/30756
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A collagen matrix material is charged with a cell growth-promoting derived nucleic acid sequence. The nucleic acid sequence-charged collagen matrix material may be utilized in a method of promoting regeneration of surface cartilage of a joint. In the method, an area of injury is covered with the nucleic acid sequence-charged collagen matrix material, the collagen matrix material is fixed over the area to be treated, and the area is allowed to heal.
Claims
exact text as granted — not AI-modified1 . A collagen matrix material comprised of a membrane substantially made up of collagen I, collagen III or a mixture thereof, the matrix material carrying a cell growth-promoting derived nucleic acid sequence, wherein said membrane comprises a barrier layer which acts as a barrier to inhibit passage of cells therethrough.
2 . The collagen matrix material of claim 1 , wherein said barrier layer has at least one smooth face so as to inhibit cell adhesion thereon, said barrier layer further having a fibrous face opposite said smooth face.
3 . The collagen matrix material of claim 2 , comprised of a multi-layer sheet of collagen membrane material, wherein said multi-layer sheet of collagen membrane material comprises said at least one barrier layer which acts as a barrier to inhibit passage of cells therethrough, wherein said sheet of collagen membrane material further comprises a matrix layer predominately of collagen II having an open sponge-like texture, wherein said matrix layer is adhered to said fibrous face.
4 . The collagen matrix material of claim 3 wherein said sequence is an isolated nucleic acid sequence.
5 . The collagen matrix material of claim 3 wherein said sequence is an isolated gene sequence.
6 . The collagen matrix material of claim 3 wherein said sequence is an isolated DNA sequence.
7 . The collagen matrix material of claim 3 wherein said sequence promotes cartilage growth.
8 . The collagen matrix material of claim 3 wherein said sequence promotes bone growth.
9 . A method of promoting regeneration of surface cartilage of a joint, comprising covering an area of damaged cartilage of a joint to be treated, with a collagen matrix material according to claim 1 , said collagen matrix material carrying a cell growth-promoting nucleic acid sequence; fixing said collagen matrix material over said area; and allowing said area to regenerate cartilage.
10 . The method of claim 9 wherein said collagen matrix material is comprised of a membrane comprised substantially of collagen I, collagen III or a mixture thereof.
11 . The method of claim 9 wherein said collagen matrix material is a multi-layer sheet of collagen membrane material, wherein said multi-layer sheet is comprised of at least one barrier layer which acts as a barrier to inhibit passage of cells therethrough, wherein said sheet of collagen membrane material further comprises a matrix layer substantially of collagen II having an open sponge-like texture.
12 . The method of claim 11 wherein said barrier layer has at least one smooth face so as to inhibit cell adhesion thereon, said barrier layer further having a fibrous face opposite said smooth face, wherein said matrix layer is adhered to said fibrous face.
13 . The method of claim 11 wherein said barrier layer is comprised of collagen I, collagen III or a mixture thereof.
14 . A method of repairing injury or damage to bone, cartilage or a combination thereof, comprising covering an area to be treated of injured or damaged bone, cartilage or a combination thereof, with a collagen matrix material according to claim 1 , said collagen matrix material carrying a cell growth-promoting derived nucleic acid sequence; fixing said collagen matrix material over said area; and allowing said area to heal.
15 . The method of claim 14 wherein said collagen matrix material is comprised of a membrane comprised substantially of collagen I, collagen III or a mixture thereof.
16 . The method of claim 14 wherein said collagen matrix material is a multi-layer sheet of collagen membrane material, wherein said multi-layer sheet is comprised of at least one barrier layer which acts as a barrier to inhibit passage of cells therethrough, wherein said sheet of collagen membrane material further comprises a matrix layer substantially of collagen II having an open sponge-like texture.
17 . The method of claim 16 wherein said barrier layer has at least one smooth face so as to inhibit cell adhesion thereon, said barrier layer further having a fibrous face opposite said smooth face, wherein said matrix layer is adhered to said fibrous face.
18 . The method of claim 16 wherein said barrier layer is comprised of collagen I, collagen III or a mixture thereof.
19 . The method of claim 14 wherein said area is a dental area, maxilofacial area or spinal area.Join the waitlist — get patent alerts
Track US2005186283A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.